Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Soleno Therapeutics Inc (SLNO)

Soleno Therapeutics Inc (SLNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,374,862
  • Shares Outstanding, K 33,411
  • Annual Sales, $ 0 K
  • Annual Income, $ -38,990 K
  • 60-Month Beta -1.40
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 9.50
Trade SLNO with:

Options Overview Details

View History
  • Implied Volatility 62.42% ( +0.57%)
  • Historical Volatility 52.14%
  • IV Percentile 1%
  • IV Rank 5.61%
  • IV High 145.78% on 03/05/24
  • IV Low 57.46% on 05/17/24
  • Put/Call Vol Ratio 258.50
  • Today's Volume 1,038
  • Volume Avg (30-Day) 445
  • Put/Call OI Ratio 4.08
  • Today's Open Interest 2,831
  • Open Int (30-Day) 5,180

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.63
  • Number of Estimates 3
  • High Estimate -0.59
  • Low Estimate -0.65
  • Prior Year -0.81
  • Growth Rate Est. (year over year) +22.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
39.04 +2.66%
on 06/24/24
49.15 -18.45%
on 06/12/24
-1.08 (-2.62%)
since 05/24/24
3-Month
36.61 +9.48%
on 04/19/24
53.80 -25.50%
on 04/29/24
-1.93 (-4.59%)
since 03/22/24
52-Week
3.69 +986.18%
on 09/07/23
53.82 -25.53%
on 02/28/24
+35.63 (+800.67%)
since 06/23/23

Most Recent Stories

More News
Why Soleno Therapeutics Stock Is Skyrocketing Today

The clinical-stage biotech company received great news from the FDA.

SLNO : 40.08 (-2.60%)
Why Soleno Therapeutics Stock Ticked Higher on Thursday

The latest pundit take on the stock provided a good reason for bulls to snap it up.

SLNO : 40.08 (-2.60%)
Why Shares of Soleno Therapeutics Dropped on Wednesday

Investors took profits a day after the clinical-stage biotech company's shares soared.

SLNO : 40.08 (-2.60%)
Why Shares of Soleno Therapeutics Are Booming on Tuesday

Soleno announced positive top-line results for DCCR, its lead therapy.

SLNO : 40.08 (-2.60%)
Three Healthcare Penny Stocks to Watch In The New Year

These three penny (and nickel) stocks in the healthcare sector have a lot of potential for 2023, and definitely worth watching.

ACRX : 0.8600 (+7.50%)
HAPP : 4.50 (+1.35%)
SLNO : 40.08 (-2.60%)
Pre-Market Brief: Stocks Mostly Lower as Economic Outlook Darkens, BoJ Policy Shift

March S&P 500 futures (ESH23) are trending down -0.08% this morning after three major U.S. benchmark indices closed lower for a fourth straight session, with Nasdaq dropping the most as market participants'...

ESH23 : 3,957.05s (-0.09%)
META : 498.91 (+0.83%)
ICCM : 0.7665 (+4.20%)
LCID : 2.56 (+2.81%)
SLNO : 40.08 (-2.60%)
TERN : 7.52 (+4.01%)
SMCI : 826.98 (-8.65%)
Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2022 Financial Results

REDWOOD CITY, Calif., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company...

SLNO : 40.08 (-2.60%)
Soleno Therapeutics Announces Presentation of DCCR Data at the 11th International Prader-Willi Syndrome Organisation Conference

REDWOOD CITY, Calif., July 11, 2022 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company...

SLNO : 40.08 (-2.60%)
Soleno Therapeutics Presents Long Term Data for DCCR Showing Metabolic and Body Composition Improvements in Patients with PWS

Patients demonstrated statistically significant improvements in several hormonal and cardiometabolic parameters following treatment with DCCR...

SLNO : 40.08 (-2.60%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Soleno Therapeutics Inc. is a healthcare company. It develops and commercializes diagnostics, devices and therapeutics addressing unmet medical needs. The Company offers products consists of CoSense end-tidal carbon monoxide Monitor, NeoPIP Infant Resuscitator and Accessories and Serenz Nasal Relief....

See More

Key Turning Points

3rd Resistance Point 44.09
2nd Resistance Point 42.94
1st Resistance Point 42.04
Last Price 40.08
1st Support Level 39.99
2nd Support Level 38.84
3rd Support Level 37.94

See More

52-Week High 53.82
Last Price 40.08
Fibonacci 61.8% 34.67
Fibonacci 50% 28.75
Fibonacci 38.2% 22.84
52-Week Low 3.69

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar